On August 21st, Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. released its semi-annual report.
According to the announcement, the company's semi-annual operating revenue reached 484,236,510.36 yuan, representing a year-over-year increase of 12.81%. Net profit attributable to shareholders of the listed company amounted to 177,008,721.63 yuan, showing an 18.61% increase compared to the same period last year.
The announcement also revealed that among the top ten circulating shareholders, Chen Hongping emerged as a new circulating shareholder.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments